Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2022-03-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-022-03167-8PMID 35254477PMCID PMC10992358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation

  2021cited by this paper
• Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression

  2021cited by this paper
• KDM5B promotes self‐renewal of hepatocellular carcinoma cells through the microRNA‐448–mediated YTHDF3/ITGA6 axis

  2021cited by this paper
• KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D

  2021cited by this paper
• Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A/HOXA1/MEIS3 Pathway

  2021influential reference
• The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma

  2021cited by this paper
• Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression

  2020cited by this paper
• Epigenetic Therapies for Cancer.

  2020cited by this paper
• The ageing epigenome and its rejuvenation

  2020cited by this paper
• Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation

  2020cited by this paper
• Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression

  2020cited by this paper
• RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A

  2020cited by this paper
• CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling

  2020cited by this paper
• Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma

  2020cited by this paper
• Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.

  2020cited by this paper
• miR24‐2 accelerates progression of liver cancer cells by activating Pim1 through tri‐methylation of Histone H3 on the ninth lysine

  2020cited by this paper
• A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival

  2020cited by this paper
• Histone lysine demethylases and their functions in cancer

  2020cited by this paper
• ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation

  2020cited by this paper
• Puerarin 6″‐O‐xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR

  2020cited by this paper
• Crucial Functions of the JMJD1/KDM3 Epigenetic Regulators in Cancer

  2020cited by this paper
• Epidemiology of Hepatocellular Carcinoma

  2020cited by this paper
• Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer

  2020cited by this paper
• Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells.

  2019cited by this paper
• Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

  2019cited by this paper
• BCOR involvement in cancer

  2019cited by this paper
• The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

  2019cited by this paper
• The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.

  2019cited by this paper
• Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma

  2019cited by this paper
• Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review

  2019cited by this paper
• Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis.

  2018cited by this paper
• Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer

  2018cited by this paper
• KDM5 demethylases and their role in cancer cell chemoresistance

  2018cited by this paper
• HPV16 E7‐induced upregulation of KDM2A promotes cervical cancer progression by regulating miR‐132–radixin pathway

  2018cited by this paper
• LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.

  2018cited by this paper
• Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges

  2018cited by this paper
• KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC

  2018cited by this paper
• STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

  2018cited by this paper
• Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer

  2017cited by this paper
• TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.

  2017cited by this paper
• UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

  2017cited by this paper
• Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation

  2017cited by this paper
• GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

  2017cited by this paper
• Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A

  2016cited by this paper
• NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

  2016cited by this paper
• Histone Modifications and Cancer.

  2016cited by this paper
• Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma.

  2016cited by this paper
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

  2016cited by this paper
• Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27

  2016cited by this paper
• Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma

  2016cited by this paper
• Lysine-Specific Demethylase 2 Suppresses Lipid Influx and Metabolism in Hepatic Cells

  2015cited by this paper
• Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells.

  2015cited by this paper
• NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.

  2014cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Histone lysine demethylases in breast cancer.

  2013cited by this paper
• Histone lysine methylation dynamics: establishment, regulation, and biological impact.

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Epigenetic Therapies for Cancer

  2011cited by this paper
• Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

  2011cited by this paper
• Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.

  2010cited by this paper
• The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function

  2010cited by this paper
• A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

  2010cited by this paper
• Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma

  2009cited by this paper
• The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.

  2009cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma

  2007cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

  2004cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Gene expression patterns in human liver cancers.

  2002cited by this paper
• Cancer statistics

  1989cited by this paper

• Expression landscape of epigenetic genes in human hepatocellular carcinoma

  2025cites this paper
• RETRACTED ARTICLE: Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A

  2025cites this paper
• Discovery and structural studies of histone demethylases

  2025cites this paper
• Overexpression of KDM6A in Hepatoma Cells Induces Hepatocytic Differentiation and Attenuates Proliferation Rate, Colony Formation, and Migration Capacities

  2025cites this paper
• Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

  2025cites this paper
• Epigenetic mechanisms in HCC immune landscape: Therapeutic implications.

  2025cites this paper
• KDM3A Modulates Trastuzumab Resistance in HER2- Positive Breast Cancer Cells via the PI3K/AKT/ERK Pathway.

  2025cites this paper
• Histone demethylases regulate ferroptosis in metabolic dysfunction‐associated steatotic liver disease via epigenetic modification

  2025cites this paper
• Lysine demethylases 6 A and 6B as epigenetic regulators in therapeutic resistance of cancer

  2025cites this paper
• 2-oxoglutarate-dependent Dioxygenases (2-OGDDs) as Oxygen Sensors: Their Importance in Health and Disease.

  2024cites this paper
• Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9

  2024cites this paper
• Apigenin inhibits lipid metabolism of hepatocellular carcinoma cells by targeting the histone demethylase KDM1A.

  2024cites this paper
• Histone demethylases in the regulation of immunity and inflammation

  2023cites this paper
• JMJD5 inhibits lung cancer progression by facilitating EGFR proteasomal degradation

  2023cites this paper
• Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy.

  2023cites this paper
• The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy

  2023cites this paper
• JMJD5 inhibits lung cancer progression by regulating glucose metabolism through the p53/TIGAR pathway

  2023cites this paper
• The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.

  2023cites this paper
• Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype

  2022cites this paper